FDA-Duke Global Regulatory Pre-Workshop
White Flint Amphitheater
Date: Tuesday, May 7, 2019
8:00 – 8:30 AM
Registration/Continental Breakfast
8:30 – 8:35 am
Session I: International Regulators’ Forum
Agnes Chan | Singapore HSA |
Larissa Higgins | EMA Representative |
Jaigi Mathai | Health Canada |
Jan Mueller-Berghaus | Germany PEI |
Sumimasa Nagai | Japan PMDA |
Kelly Norsworthy | US FDA |
Ho Jung Oh | Korea MFDS |
Anuradha Poonepalli | Singapore HSA |
S. Eswara Reddy | India CDSCO |
Arun Singhal | Government of India |
Joohee Sul | US FDA |
Reiko Yanagihara | Japan PMDA |
Hong Zhang | China NMPA |
Ming Zhou | China NMPA |
10:05 – 10:30 am
Break
Session II: Academic Investigators’ Perspectives
Panelists
Xiaoyuan Chen | Tsinghua University |
Thomas Gross | National Cancer Institute |
Abiola Ibraheem | University of Chicago |
University of Chicago | |
Jun Ren | China Capital Medical University |
Martin Stockler | The University of Sydney |
11:45 – 12:45 pm
Lunch
Session III: Oncology Drug Development and Approval in China
Panelists
Tao Fu | Zai Laboratory |
Xiaoyuan Chen | Tsinghua University |
Frank Jiang | CStone |
Jian Peng | Shenogen Pharma Group |
Dan Zhang | Fountain Medicine |
2:05 – 2:25 pm
Break
2:25 – 3:45 pm
Moderator
Joseph Arena, Pfizer
Session IV: Industry’s View on Global Drug Development
Panelists
Jonathan Cheng | Merck |
Chitkala Kalidas | Bayer |
Geoff Kim | AstraZeneca |
Rominder Singh | Pfizer |
Craig Tendler | Janssen |
3:45 – 4:45 pm
Moderator
Kate Rawson, Prevision Policy
Session V: What Media Say about Global Drug Development
Panelists
Joshua Berlin | Biocentury |
Nielsen Hobbs | The Pink Sheet |
Sarah Karlin-Smith | Politico |
Steve Usdin | Biocentury |
Craig Tendler | Janssen |